Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2025-12-25 @ 10:21 PM
NCT ID: NCT03081858
Term: Extraperitoneal Bladder abscess
Organ System: Renal and urinary disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA,Version 20.1
Notes: In Part 3, follow-up from part 1, patient with recurrent TaN0M0 bladder cancer (intermediate risk category) who was hospitalized for extraperitoneal bladder rupture and abscess due to complications of TURBT. Assessed as severe, unrelated to IP.
Study: NCT03081858
Study Brief: Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG004 1 1 10 View
EG000 0 0 3 View
EG001 0 0 3 View
EG002 0 0 6 View
EG003 0 0 3 View